Evidence map›Paper›PMID 42145868›Full record

ArticleClinical, cosmetic and investigational dermatology2026

Bidirectional Mendelian Randomization Suggests Causal Effects of 731 Immunophenotypes on Vitiligo Pathogenesis.

Ziyi Lin, Ruozhou Qi, Huanhuan Deng, Rule Sa, Yi Chen, Min Huang, Yongxiang Long, Guangshan Chen, Xingwu Duan

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ziyi LinDepartment of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Ruozhou QiDepartment of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.ORCID 0009-0004-1210-3354
Huanhuan DengDepartment of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Rule SaDepartment of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Yi ChenDepartment of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Min HuangDepartment of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Yongxiang LongDepartment of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Guangshan ChenDepartment of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Xingwu DuanDepartment of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This two-sample Mendelian randomization (MR) study aimed to investigate the causal relationship between 731 immune cell traits and vitiligo. Patients and Methods: Genetic variants with genome-wide suggestive significance ( Results: The onset of vitiligo was significantly associated with reduced levels of TD CD4 Conclusion: We suggest novel causal links between vitiligo and specific immune cell dysregulation, highlighting the pivotal role of adaptive immunity in pathogenesis and informing potential therapeutic targets such as TD CD4

Indexed as

autoimmunitycausal inferenceimmune phenotypingmendelian randomizationvitiligo

Identifiers

PMID42145868
PMCPMC13178483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.